Tue, 12/20/2022 - 20:00 |
Gene therapy corrects mutation responsible for common heart condition, research shows |
UTSouthwestern |
Tue, 12/20/2022 - 14:42 |
BiondVax Announces Closing of $8 Million Underwritten Public Offering |
BiondVax Pharma... |
Tue, 12/20/2022 - 09:34 |
USDA Invests $9.5M to Develop New Bioproducts from Agricultural Commodities |
USDA |
Mon, 12/19/2022 - 19:38 |
Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Board |
Nascent Biotech |
Mon, 12/19/2022 - 10:16 |
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2 Test |
Biodesix |
Mon, 12/19/2022 - 05:36 |
Soligenix Initiates Phase 2 Clinical Trial of SGX302 (synthetic hypericin) for the Treatment of Mild-to-Moderate Psoriasis |
Soligenix |
Fri, 12/16/2022 - 13:31 |
Mintz Announces New Member Growth |
Mintz |
Fri, 12/16/2022 - 03:21 |
CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec Gene Therapy for Adults with Hemophilia B |
CSL Behring |
Fri, 12/16/2022 - 01:31 |
Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb |
Evotec |
Thu, 12/15/2022 - 09:38 |
Virginia Bio Celebrates its 30th Anniversary, Welcomes Five New Directors to its Board |
VABIO |
Thu, 12/15/2022 - 07:38 |
CASI Pharmaceuticals Partner Juventas Announces New Drug Application For CNCT19 Accepted By China National Medical Products Administration |
CASI Pharmaceuticals |
Thu, 12/15/2022 - 06:28 |
bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench |
BioAffinity Tec... |
Thu, 12/15/2022 - 04:55 |
Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day |
Alnylam |
Wed, 12/14/2022 - 13:43 |
Researchers Receive $3.2 Million for Diabetes Treatment Testing |
MU School of Me... |
Wed, 12/14/2022 - 02:37 |
BioBuzz Workforce Champion Award goes to Wistars New Biomedical Technician Training Program for Adults |
Wistar Institute |
Tue, 12/13/2022 - 23:17 |
BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures |
VABIO |
Tue, 12/13/2022 - 22:46 |
Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund |
Fujifilm |
Tue, 12/13/2022 - 10:51 |
Next-Generation Drug Improves Progression-Free Survival in Relapsed Chronic Lymphocytic Leukemia |
Dana Farber |
Mon, 12/12/2022 - 17:59 |
CSL Announces Next CEO & Managing Director |
CSL Behring |
Mon, 12/12/2022 - 09:17 |
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 |
Oxis Biotech |
Mon, 12/12/2022 - 06:49 |
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine |
Biodesix |
Mon, 12/12/2022 - 01:05 |
Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia |
VABIO |
Fri, 12/09/2022 - 15:14 |
CHICAGO (December 9, 2022) Hyatt Hotels Corporation (NYSE: H) today announced Hyatt Place Chengdu Bio-Town, the second Hyatt Place hotel in Chengdu, expanding the Hyatt Place brands footprint globally in markets that matter most to guests and World of H |
Hyatt Hotels |
Tue, 12/06/2022 - 10:36 |
Activation Capital Names New Vice President for Operations |
VABIO |
Tue, 12/06/2022 - 08:26 |
Cystic Fibrosis Foundation Announces Irena Barisic as Next Chief Operating and Financial Officer |
Cystic fibrosis |